Abstract:The management of headaches in children and adolescents is still a challenge, with patients experiencing pain for years and polypharmacy. We reviewed the medical history of 31 patients referred to our pain clinic for chronic headaches between April 2023 and April 2024. There were more female than male patients (73%). Patients have been reporting headaches for 52 ± 44 months on average. Twenty-nine patients (94%) were experiencing different types of pain besides headaches. The most common medication prescribed in this group of patients was topiramate (70%), followed by tricyclic antidepressants (35%) and triptans (21%). Patients had been prescribed and tried, on average, 4.5 ± 2 (range 1–10) different medications to manage headaches and concomitant psychiatric disorders. Twenty-two patients (71%) had been diagnosed with a psychiatric disorder, including depression, anxiety, and PTSD, and 16% had a history of attempted suicide/self-harm. Fourteen of them (45%) had been prescribed antidepressants or benzodiazepines. They had been prescribed, on average, 2 ± 1 (range 1–4) psychiatric stabilizer medications. We agreed with the referral diagnosis in 39% of the patients. We attributed the headaches to more complex chronic pain conditions, including fibromyalgia (15%) and AMPS (15%), autism with sensory integration problems (9%), and major depression (9%). Patients had seen an average of 3 ± 1 (range 1–5) different specialists; none consulted a pain specialist. Patients underwent between 0 (12%) and four tests (6%), including MRI (52%) and CT of the brain (8%). These neuroimaging studies did not demonstrate any brain pathology. We prescribed new medications and treatments, including nerve blocks, in 19 (61%) patients. In 47% of the cases, patients reported improved headaches, while 22% did not feel our recommendations were effective. Twenty-one percent of patients never came back to the clinic for a follow-up. Significant catastrophizing was present in 57% of the patients; 52% of patients had mild to severe anxiety, and 57% had symptoms of depressive disorder. Conclusions : Headaches are often the manifestation of more complex pain syndromes that require a more holistic approach, different from conventional pharmacological management. What is Known: • Headache is one of the most disabling diseases. • Prevalence of headaches in hildrens and adolescents can be as high as 58%. What is New: • Conventional pharmacological management often fails to help young patients. • A relationship between chronic headaches and psychopathology should be investigated in these young patients.

[Modern principles of primary headaches prevention in children and adolescents]

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

The clinical characteristics of primary headache and associated factors in children: A retrospective descriptive study

Headaches and adolescents: why so many failures in their management

Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents

Secondary intracranial causes for headaches in children

Sex and age-related patterns in pediatric primary headaches: observations from an outpatient headache clinic

Primary headache syndromes in the elderly: epidemiology, diagnosis and treatment

Depression, Sex-Roles, and Family Variables: Comparison of Bulimics, Binge-Eaters, and Normals

Hallmarks of primary headache: part 1 – migraine

Modern ideas about cluster headache. Literature review

Nonpharmacologic Treatment Options in Pediatric Tension-Type Headache Patients: A Systematic Review

Association of diet and headache

Headache and comorbidity in children and adolescents

Association of lifestyle factors with the prevalence and nature of headache in adolescents

Primary headache content on online community platforms: a scoping review protocol

Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea

Non-Pharmacological Treatment of Primary Headaches—A Focused Review

New Daily Persistent Headache in the Pediatric and Adolescent Population: An Updated Review

HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.